Moolec Science SA (MLEC) Stock Analysis
Verdict: AVOID
Severe cash burn ($30.1M FY25 FCF loss) and under $1.1M in cash create immediate dilution and going-concern risk despite GLASO progress.
Investment score: 14/100
Analysis as of
Is Moolec Science SA stock worth reviewing? AI model thesis
The AI model views MLEC as a high-risk distressed microcap facing an acute cash runway deficit, severe debt liabilities, and substantial equity dilution risk.
7-factor investment score
- Valuation: 10/100 (weight 20%)
- Financial Health: 5/100 (weight 15%)
- Technical Momentum: 10/100 (weight 15%)
- Earnings Quality: 15/100 (weight 15%)
- Insider Sentiment: 30/100 (weight 10%)
- Analyst Consensus: 25/100 (weight 10%)
- Risk-Adjusted Return: 10/100 (weight 15%)
Moolec Science SA opportunities and risks
What speaks for MLEC
- GLASO Safflower Commercial Expansion
What speaks against MLEC
- Existential Cash Runway Deficit
Frequently asked questions about Moolec Science SA (MLEC)
Is MLEC stock a good investment?
The cached TradeMates AI model rates Moolec Science SA as AVOID with an investment score of 14/100. The AI model views MLEC as a high-risk distressed microcap facing an acute cash runway deficit, severe debt liabilities, and substantial equity dilution risk. This is algorithmic model output, not personal investment advice.
Is MLEC stock a buy?
The TradeMates model verdict for MLEC is AVOID with an investment score of 14/100. Treat this as a model signal to review, not a personal buy recommendation.